Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $29.87 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BeiGene USA, Inc. | $17.95 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $17.95 | 1 | BeiGene USA, Inc. ($17.95) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Education | In-kind items and services | $17.95 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 770 | 1,756 | $669,421 | $149,542 |
| 2022 | 5 | 824 | 1,861 | $623,927 | $153,535 |
| 2021 | 5 | 936 | 1,795 | $584,359 | $153,668 |
| 2020 | 7 | 946 | 1,966 | $614,870 | $136,769 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 161 | 663 | $302,207 | $71,799 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 509 | 992 | $324,915 | $68,426 | 21.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $20,265 | $4,739 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $13,740 | $2,960 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $8,294 | $1,618 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 534 | 1,089 | $326,168 | $75,632 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 149 | 616 | $248,140 | $67,610 | 27.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 35 | 35 | $20,067 | $4,562 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 102 | $20,934 | $3,996 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $8,618 | $1,734 | 20.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 189 | 675 | $257,508 | $74,429 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 552 | 914 | $258,957 | $62,572 | 24.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 55 | 55 | $29,667 | $7,649 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 114 | $22,398 | $5,295 | 23.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $15,829 | $3,724 | 23.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 573 | 1,078 | $286,372 | $61,004 | 21.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 199 | 713 | $255,110 | $60,885 | 23.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 75 | 75 | $33,796 | $7,415 | 21.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 37 | 37 | $30,627 | $4,709 | 15.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 32 | $5,984 | $1,179 | 19.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 17 | $1,837 | $1,027 | 55.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 14 | $1,144 | $548.99 | 48.0% |
About Dr. Nicholas Paphitis, M.D
Dr. Nicholas Paphitis, M.D is a Hematology & Oncology healthcare provider based in Fishersville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780772137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Paphitis, M.D has received a total of $29.87 in payments from pharmaceutical and medical device companies, with $17.95 received in 2022. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Education" ($29.87).
As a Medicare-enrolled provider, Paphitis has provided services to 3,476 Medicare beneficiaries, totaling 7,378 services with total Medicare billing of $593,513. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Fishersville, VA
- Active Since 10/11/2006
- Last Updated 01/02/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780772137
Products in Payments
- BRUKINSA (Drug) $17.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.